Mitochondrial haplogroups and polymorphisms reveal no association with sporadic prostate cancer in a southern European population

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Álvarez Cubero, María Jesús ^a   Saiz Guinaldo, María ^a   Martínez González, Luís Javier ^b   Álvarez Merino, Juan Carlos ^a,b   Cózar Olmo, José Manuel ^c   Acosta, José Antonio Lorente ^a,b  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA;

AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; DNA SEQUENCE; ETHNIC GROUP; EUROPEAN; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GLEASON SCORE; HAPLOGROUP; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MITOCHONDRIAL GENOME; PROSTATE CANCER; SPORADIC PROSTATE CANCER;

AGED; CASE-CONTROL STUDIES; DNA, MITOCHONDRIAL; EUROPE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA; ODDS RATIO; POLYMORPHISM, GENETIC; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SEQUENCE ANALYSIS, DNA; SPAIN;

EID: 84864010842     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041201     Document Type: Article

References (60)

1. Quaglia A, Parodi S, Grosclaude P, Martinez-Garcia C, Coebergh JW, et al. (2003) Differences in the epidemic rise and decrease of prostate cancer among geographical areas in Southern Europe: an analysis of differential trends in incidence and mortality in France, Italy and Spain. European Journal of Cancer 39: 654-665.
2. Ferlay J, Bray F, Pisani P, Parkin DM, (2001) GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide, version 1.0. IARC CancerBase 5: x-x.
3. Isaacs WB, Xu J, (2007) Linkage Studies of Prostate Cancer Families to Identify Susceptibility Genes. Human Press Inc, Totowa, New Jersey.
4. Alvarez-Cubero MJ, Entrala C, Fernandez-Rosado F, Martinez-Gonzalez LJ, Alvarez JC, et al. (2011) Predictive value in the analysis of RNASEL genotypes in relation to prostate cancer. Prostate Cancer and Prostatic Diseases.
5. Wang L, McDonnell SK, Elkins DA, Slager SL, Christensen E, et al. (2002) Analysis of the RNASEL gene in familial and sporadic prostate cancer. Am J Hum Genet 71: 116-123.
6. C Alberti, (2010) Hereditary/familial versus sporadic prostate cancer: few indisputable genetic differences and many similar clinicopathological features. Eur Rev Med Pharmacol Sci 14(1): 31-41.
7. Griffiths AJF, Miller JH, Suzuki DT, Lewontin RC, Gelbart WM, (2000) An Introduction to Genetic Analysis., New York.
8. Petros JA, Baumann AK, Ruiz-Pesini E, Amin MB, Qi Sun C, et al. (2005) mtDNA mutations increase tumorigenicity in prostate cancer. PNAS 102: 719-724.
9. Wang L, McDonnell SK, Hebbring SJ, Cunningham JM, St Sauver J, et al. (2008) Polymorphisms in Mitochondrial Genes and Prostate Cancer Risk. Cancer Epidemiol Biomarkers Prev 17: 3558-3566.
10. Booker LM, Habermacher GM, Jessie BC, Sun QC, Baumann AK, et al. (2006) North American white mitochondrial haplogroups in prostate and renal cancer. J Urol 175: 468-472.
11. Brandon M, Baldi P, Wallace DC, (2006) Mitochondrial mutations in cancer. Oncogene 25(34): 4647-4662.
12. Lu J, Sharma LK, Bai Y, (2009) Implications of mitochondrial DNA mutations and mitochondrial dysfunction in tumorigenesis. Cell Res 19(7): 802-815.
13. Chatterjee A, Mambo E, Sidransky D, (2006) Mitochondrial DNA mutations in human cancer. Oncogene 25(34): 4663-4674.
14. Yu JJ, Yan T, (2010) Effect of mtDNA mutation on tumor malignant degree in patients with prostate cancer. Aging Male 13: 159-165.
15. Kloss-Brandstätter A, Schäfer G, Erhart G, Hüttenhofer A, Coassin S, et al. (2010) Somatic mutations throughout the entire mitochondrial genome are associated with elevated PSA levels in prostate cancer patients. Am J Hum Genet 87: 802-812.
16. Ray K, (2011) Genetics: mtDNA mutations key to prostate cancer development?. Nature Reviews Urology 8: 119.
17. Kumar V, Yadav CS, Singh S, Goel S, Ahmed RS, et al. (2010) CYP 1A1 polymorphism and organochlorine pesticides levels in the etiology of prostate cancer. Chemosphere 81: 464-468.
18. Xu J, Dimitrov L, Chang B, Adams TS, Turner AR, et al. (2005) A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the International Consortium for Prostate Cancer Genetics. Am J Hum Genet 77: 219-229.
19. Chang B, Lange EM, Dimitrov L, Valis CJ, Gillanders EM, et al. (2006) Two-locus genome-wide linkage scan for prostate cancer susceptibility genes with an interaction effect. Hum Genet 118: 716-724.
20. Kim W, Yoo TK, Shin DJ, Rho HW, Jin HJ, et al. (2008) Mitochondrial DNA Haplogroup Analysis Reveals no Association between the Common Genetic Lineages and Prostate Cancer in the Korean Population. PLoS ONE 3(5): e2211-e2211.
21. Mueller EE, Eder E, Mayr JA, Paulweber B, Sperl W, et al. (2009) Mitochondrial Haplogroups and Control Region Polymorphisms Are Not Associated with Prostate Cancer in Middle European Caucasians. PLoS ONE 4(7): e6370-e6370.
22. Andrews RM, Kubacka I, Chinnery PF, Lightowlers RN, Turnbull DM, et al. (1999) Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet 23: 147.
23. Ingman M, Gyllensten U, (2006) mtDB: Human Mitochondrial Genome Database, a resource for population genetics and medical sciences. Nucleic Acids Res 34: D749-D751.
24. Ruiz-Pesini E, Lott MT, Procaccio V, Poole JC, Brandon MC, et al. (2007) An enhanced MITOMAP with a global mtDNA mutational phylogeny. Nucleic Acids Res 35: D823-D828.
25. van Oven M, Kayser M, (2009) Updated comprehensive phylogenetic tree of global human mitochondrial DNA variation. Hum Mutat 30: E386-394.
26. Howell N, Elson JL, Howell C, Turnbull DM, (2007) Relatives rates of evolution in the coding and control regions of African mtDNAs. Mol Biol Evol 24(10): 2213-2221.
27. Fang H, Shen L, Chen T, He J, Ding Z, et al. (2010) Cancer type-specific modulation of mitochondrial haplogroups in breast,colorectal and thyroid cancer. BMC Cancer 10: 421-431.
28. Hulgan T, Haubrich R, Riddler SA, Tebas P, Ritchie MD, et al. (2011) European mitochondrial DNA haplogroups and metabolic changes during antiretroviral therapy in AIDS Clinical Trials Group Study A5142. AIDS 25: 37-47.
29. Wiesbauer M, Meierhofer D, Mayr JA, Sper W, Paulweber B, et al. (2006) Multiplex primer extension analysis for rapid detection of major European mitochondrial haplogroups. Mitochondrion(Abstract) 6: 263-288.
30. Alvarez JC, Johnson DLE, Lorente JA, Martinez-Espin E, Martinez-Gonzalez LJ, et al. (2007) Characterization of human control region sequences for Spanish individuals in a forensic mtDNA data set. Leg Med 9: 293-304.
31. Kofler B, Mueller EE, Eder W, Stanger O, Maier R, et al. (2009) Mitochondrial DNA haplogroup T is associated with coronary artery disease and diabetic retinopathy: a case control study. BMC Med Genet 10: 35.
32. Bai R, Leal SM, Covarrubias D, Liu A, Wong LC, (2007) Mitochondrial genetic background modifies breast cancer risk. Cancer Res 67: 4687-4694.
33. Wang L, Bamlet WR, de Andrade M, Boardman LA, Cunningham JM, et al. (2007) Mitochondrial genetic polymorphisms and pancreatic cancer risk. Cancer Epidemiology Biomarkers and Prevention 16: 1455-1459.
34. Kirches E, Krause G, Warich-Kirches M, Weis S, Schneider T, et al. (2001) High frequency of mitochondrial DNA mutations in glioblastoma multiforme identified by direct sequence comparison to blood samples. International Journal of Cancer 93: 534-538.
35. Tan D, Bai R, Wong LC, (2002) Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res 62: 972-976.
36. Kurtz A, Lueth M, Kluwe L, Zhang T, Foster R, et al. (2004) Somatic mitochondrial DNA mutations in neurofibromatosis type 1-associated tumors. Molecular Cancer Research 2: 433-441.
37. Snäll N, Savontaus M, Kares S, Myung LS, Eun KC, et al. (2002) A rare mitochondrial DNA haplotype observed in Koreans. Human Biology 74: 253-262.
38. Jerónimo C, Nomoto S, Caballero OL, Usadel H, Henrique R, et al. (2001) Mitochondrial mutations in early stage prostate cancer and bodily fluids. Oncogene 20: 5195-5198.
39. Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, et al. (2000) Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 287: 2017-2019.
40. O'Dowd GJ, Veltri RW, Miller MC, Strum SB, (2001) The Gleason Score: A Significant Biologic Manifestation of Prostate Cancer Aggressiveness On Biopsy. PCRI Insights 4.
41. Gleason D, (1966) Classification of prostate carcinomas. Cancer Chemother Rep 50: 125-128.
42. Durham S, Krishnan K, Betts J, Birch-Machin M, (2003) Mitochondrial DNA damage in non-melanoma skin cancer. Br J Cancer 88: 90-95.
43. Universidad Católica de Chile (Martinez L., Manual de Urología esencial) website. Available:http://escuela.med.puc.cl/publ/manualurologia/CancerProstata.html. Accessed 2012 Jun 26.
44. Baillar J, Mellinger G, Gleason D, (1966) Survival rates of patients with prostatic cancer, tumor stage and differentiation- a preliminary report. Cancer Chemotherap Rep 50:129-136, 1966. Cancer Chemotherap Rep 50: 129-136.
45. Chen JZ, Kadlubar FF, (2004) Mitochondrial mutagenesis and oxidative stress in human prostate cancer. J Environ Sci Health Part C Environ Carcinog Ecotoxicol Rev 22: 1-12.
46. Akouchekian M, Houshmand M, Hemati S, Ansaripour M, Shafa M, (2009) High rate of mutation in mitochondrial DNA displacement loop region in human colorectal cancer. Diseases of the Colon & Rectum 52: 526.
47. Jessie BC, Sun CQ, Irons HR, Marshall FF, Wallace DC, et al. (2001) Accumulation of mitochondrial DNA deletions in the malignant prostate of patients of different ages. Exp Gerontol 37: 169-174.
48. Tseng L, Yin P, Yang C, Tsai Y, Hsu C, et al. (2011) Somatic mutations of the mitochondrial genome in human breast cancers. Genes Chromosomes Cancer 50: 800-811.
49. Liu S, Jiang R, Chen F, Wang W, Lin J, (2011) Somatic mutations in the D-loop of mitochondrial DNA in oral squamous cell carcinoma. Eur Arch Oto-Rhino-Laryngol pp. 1-6.
50. Gómez-Zaera M, Abril J, González L, Aguiló F, Condom E, et al. (2006) Identification of somatic and germline mitochondrial DNA sequence variants in prostate cancer patients. Mutat Res Fundam Mol Mech Mutagen 595: 42-51.
51. Shaik NA, Lone WG, Khan IA, Vaidya S, Rao KP, et al. (2011) Detection of somatic mutations and germline polymorphisms in mitochondrial DNA of uterine fibroids patients. Gent Test and Mol Biomarkers 15: 537-541.
52. Gleason DF, (1992) Histologic grading of prostate cancer: a perspective. Hum Pathol 23: 273-279.
53. Gleason DF, (1966) Classification of prostatic carcinomas. Cancer Chemother Rep 50: 125-128.
54. Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, et al. (2004) Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter. N Engl J Med 350: 2239-2246+2321.
55. National Geographic website. Available:http://nnhgtool.nationalgeographic.com/classify/index.html. Accessed 2012 Jun 26.
56. Fabrini E website. Available:http://www.doppiovu3.it/mtdna/aplo/aplo_en.htm. Accessed 2012 Jun 26.
57. Lee HY, Song I, Ha E, Cho SB, Yang WI, et al. (2008) mtDNAmanager: a Web-based tool for the management and quality analysis of mitochondrial DNA control-region sequences. BMC Bioinformatics 9: 483.
58. Kloss-Brandstätter A, Pacher D, Schönherr S, Weissensteiner H, Binna R, et al. (2011) HaploGrep: A fast and reliable algorithm for automatic classification of mitochondrial DNA haplogroups. Hum Mutat 32: 25-32.
59. IBM website. Available:http://www-01.ibm.com/software/analytics/spss/. Accessed 2012 Jun 26.
60. Excoffier L, Lischer HEL, (2010) Arlequin suite ver 3.5: A new series of programs to perform population genetics analyses under Linux and Windows. Molecular Ecology Resources. Arlequin suite ver 3 5 10: 564-567.